wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53701901-5F0427E4-2272-4CAD-9E0B-3D97462CF4B8
Q53701901-5F0427E4-2272-4CAD-9E0B-3D97462CF4B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53701901-5F0427E4-2272-4CAD-9E0B-3D97462CF4B8
Developing TRAIL/TRAIL death receptor-based cancer therapies.
P2860
Q53701901-5F0427E4-2272-4CAD-9E0B-3D97462CF4B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53701901-5F0427E4-2272-4CAD-9E0B-3D97462CF4B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c54ade018a898bc336dcaf1a0289a0c56ab91e08
P2860
Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway.